Emerging and Reemerging Infectious Diseases Journal Articles

• Safety of IV Golimumab in RA, PsA, and AS A pooled analysis of data from three trials provides insight into the safety profile of IV golimumab for the treatment of these rheumatologic conditions.
  Arthritis Research & Therapy, May 18, 2022
• Risk of Herpesvirus and Serious Infections in Atopic Dermatitis This study suggests that atopic dermatitis is associated with an increased risk of hospital admission with infections, opportunistic infections and herpesvirus infections in both children and adults.
  The British Journal of Dermatology, May 10, 2022
• Decrease in Tuberculosis Cases During COVID-19 Pandemic An analysis of prescription data noted a significant decline in reported tuberculosis cases during the COVID-19 pandemic. What factors may account for the downward trend?
  Emerging Infectious Diseases, May 04, 2022
• Acute Kidney Injury is Linked to Neurocognitive Impairments A new study finds that an episode of acute kidney injury could have negative impacts on neurocognitive functioning.
  Nephrology Dialysis Transplantation, May 04, 2022
• A Young Adolescent With MIS-C-Like Illness During COVID-19 A young patient presents with MIS-C-like symptoms but no known history of or exposure to COVID-19. What differential diagnoses should be considered?
  Pediatric Nursing, May 02, 2022
• SGLT2 Inhibitors: The Statins of the 21st Century This overview of the development and clinical applications of SGLT2 inhibitors positions them as one of the major pharmacological advances in cardiovascular medicine in this century.
  European Heart Journal, April 19, 2022
• Overseas Treatment of Latent TB in US-Bound Immigrants Could TB testing and treatment of immigrants before arrival in the U.S. help prevent the importation of the disease?
  Emerging Infectious Diseases, March 22, 2022
• Outcomes in Those Aged <18 Years Hospitalized With COVID-19 Many pediatric patients in this study with COVID-19-related hospitalization had severe illness and viral coinfections, and few had been vaccinated, according to this CDC report.
  Morbidity & Mortality Weekly Report, March 21, 2022
• Safety and Efficacy of Tofacitinib for Ulcerative Colitis This paper presents final data from OCTAVE Open, an open-label, long-term extension study on the safety and efficacy of the Janus kinase inhibitor tofacitinib for the treatment of ulcerative colitis.
  Alimentary Pharmacology & Therapeutics, March 08, 2022
• Immunosuppression Withdrawal After Lupus Nephritis Remission In lupus nephritis patients in remission, could immunosuppressive therapy be safely withdrawn?
  Rheumatology, March 03, 2022
• Impact of COVID-19 on HIV Testing and Care Provision The significant impacts of the COVID-19 pandemic on access to HIV testing and treatment could have long-term consequences.
  HIV Medicine, February 24, 2022
• West Nile Virus Transmission by Solid Organ Transplantation Due to the potential for West Nile virus transmission through solid organ transplantation, should routine donor screening be considered?
  Emerging Infectious Diseases, February 23, 2022
• Zoonotic Infection With Oz Virus, a Novel Thogotovirus Learn more about the Oz virus, a tick-transmitted thogotovirus that could potentially cause infection in mammals -- including humans.
  Emerging Infectious Diseases, February 18, 2022
• Enterovirus D68-Associated Acute Respiratory Illness EV-D68 is an important pathogen causing respiratory disease in children. How prevalent has it been in the U.S. in the last few years?
  Morbidity & Mortality Weekly Report, February 11, 2022
• Neuropsychiatric Manifestations of COVID-19 This review synthesizes the neuropsychiatric manifestations of COVID-19 infection in people with psychiatric disorders. What are the most common neuropsychiatric sequelae affecting these patients?
  Journal of Medical Case Reports, February 01, 2022
• Same-Day ART Initiation for People With HIV With TB Symptoms Should people with HIV exhibiting tuberculosis symptoms be started on same-day antiretroviral therapy? A new review looks at the risks and benefits of this strategy.
  HIV Medicine, January 27, 2022
• Pulmonary Artery Involvement in TAK and Heart Diseases A new study looks at the incidence of ischemic heart diseases and infections among Takayasu arteritis patients with pulmonary artery involvement.
  Arthritis Research & Therapy, January 27, 2022
• COVID-19 and Diabetes: The Perfect Storm for Reactivation TB? This case series draws attention to the potential of a heightened risk of M. tuberculosis reactivation among COVID-19 patients with a history of chronic and poorly controlled diabetes.
  Journal of Medical Case Reports, January 20, 2022
• SARS-CoV-2 and Respiratory Virus Sentinel Surveillance A new surveillance system provides insight into the state trends for SARS-CoV-2 and other respiratory viruses throughout California during this time period.
  Emerging Infectious Diseases, January 12, 2022
• TRAPS-Related AA Amyloidosis This paper describes the frequency and prognosis of AA amyloidosis in TNF receptor-1-associated periodic syndrome. What is known about this potentially severe complication?
  Rheumatology, January 07, 2022